PLEURAL BIPHASIC MESOTHELIOMA

Clinical trials for PLEURAL BIPHASIC MESOTHELIOMA explained in plain language.

Never miss a new study

Get alerted when new PLEURAL BIPHASIC MESOTHELIOMA trials appear

Sign up with your email to follow new studies for PLEURAL BIPHASIC MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for Tough-to-Treat cancer: boosting immune system before surgery

Disease control Recruiting now

This study is testing if giving two immunotherapy drugs before surgery helps control a rare and aggressive type of lung cancer called sarcomatoid mesothelioma. The goal is to see if this approach helps more patients get to surgery and keeps the cancer from growing back longer. Re…

Matched conditions: PLEURAL BIPHASIC MESOTHELIOMA

Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

PLEURAL BIPHASIC MESOTHELIOMA

Get alerted when new PLEURAL BIPHASIC MESOTHELIOMA trials appear

New hope for Tough-to-Treat cancer: boosting immune system before surgery